 |
The Journal of Neuroscience, June 14, 2006, 26(24):6413-6421; doi:10.1523/JNEUROSCI.3815-05.2006
Previous Article | Next Article 
Neurobiology of Disease
HMGB1, a Novel Cytokine-Like Mediator Linking Acute Neuronal Death and Delayed Neuroinflammation in the Postischemic Brain
Jung-Bin Kim,1
Joon Sig Choi,2
Young-Mi Yu,1
Kihoon Nam,3
Chun-Shu Piao,1
Seung-Woo Kim,1
Min-Hyung Lee,4
Pyung-Lim Han,5
Jong-sang Park,3 and
Ja-Kyeong Lee1
1Department of Anatomy and Center for Advanced Medical Education (BK21 project), Inha University School of Medicine, Inchon 400-712, Korea, 2Department of Biochemistry, Chungnam National University, Daejeon 305-764, Korea, 3School of Chemistry and Molecular Engineering, Seoul National University, Seoul 151-742, Korea, 4Department of Bioengineering, School of Engineering, Hanyang University, Seoul 133-791, Korea, and 5Division of Nano Sciences and Department of Life Sciences, Ewha Womans University, Seoul 110-783, Korea
Correspondence should be addressed to Dr. Ja-Kyeong Lee, Department of Anatomy, Inha University School of Medicine, 7-241 Shinheung-dong, Jung-Gu, Inchon 400-712, Republic of Korea. Email: jklee{at}inha.ac.kr
Cerebral ischemic injury proceeds with excitotoxicity-induced acute neuronal death in the ischemic core and with delayed damage processes in the penumbra. However, knowledge concerning the direct mediators that connect these two processes is limited. Here, we demonstrate that high-mobility group box 1 (HMGB1), a nonhistone DNA-binding protein, is massively released into the extracellular space immediately after ischemic insult and that it subsequently induces neuroinflammation in the postischemic brain. Short hairpin (sh)RNA-mediated HMGB1 downregulation in the postischemic brain suppressed infarct size, microglia activation, and proinflammatory marker induction, indicating that HMGB1 plays a crucial role in the inflammatory process. The proinflammatory cytokine-like function of extracellular HMGB1 was further verified in primary cortical cultures and microglial cultures. HMGB1 was found to accumulate in NMDA-treated primary cortical culture media, and supernatants collected from these cultures were found to trigger microglia activation, the hallmark of brain inflammation. Moreover, treatment with recombinant HMGB1 also induced microglial activation, but HMGB1-depleted supernatant produced by anti-HMGB1 antibody treatment or by HMGB1 shRNA expression did not, thus demonstrating the essential role of HMGB1 in microglial activation. Together, these results indicate that HMGB1 functions as a novel proinflammatory cytokine-like factor that connects excitotoxicity-induced acute damage processes and delayed inflammatory processes in the postischemic brain.
Key words: HMGB1; MCAO; ischemia; inflammation; shRNA; PAMAM-Arg
Received Sept. 8, 2005;
revised April 11, 2006;
accepted April 11, 2006.
Correspondence should be addressed to Dr. Ja-Kyeong Lee, Department of Anatomy, Inha University School of Medicine, 7-241 Shinheung-dong, Jung-Gu, Inchon 400-712, Republic of Korea. Email: jklee{at}inha.ac.kr
This article has been cited by other articles:

|
 |

|
 |
 
K. A. Kigerl, J. C. Gensel, D. P. Ankeny, J. K. Alexander, D. J. Donnelly, and P. G. Popovich
Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord
J. Neurosci.,
October 28, 2009;
29(43):
13435 - 13444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kikuchi, K.-i. Kawahara, S. Tancharoen, F. Matsuda, Y. Morimoto, T. Ito, K. K. Biswas, K. Takenouchi, N. Miura, Y. Oyama, et al.
The Free Radical Scavenger Edaravone Rescues Rats from Cerebral Infarction by Attenuating the Release of High-Mobility Group Box-1 in Neuronal Cells
J. Pharmacol. Exp. Ther.,
June 1, 2009;
329(3):
865 - 874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kohno, T. Anzai, K. Naito, T. Miyasho, M. Okamoto, H. Yokota, S. Yamada, Y. Maekawa, T. Takahashi, T. Yoshikawa, et al.
Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling
Cardiovasc Res,
February 15, 2009;
81(3):
565 - 573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Muhammad, W. Barakat, S. Stoyanov, S. Murikinati, H. Yang, K. J. Tracey, M. Bendszus, G. Rossetti, P. P. Nawroth, A. Bierhaus, et al.
The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
J. Neurosci.,
November 12, 2008;
28(46):
12023 - 12031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Andersson, R. Covacu, D. Sunnemark, A. I. Danilov, A. Dal Bianco, M. Khademi, E. Wallstrom, A. Lobell, L. Brundin, H. Lassmann, et al.
Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis
J. Leukoc. Biol.,
November 1, 2008;
84(5):
1248 - 1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I.-H. Cho, J. Hong, E. C. Suh, J. H. Kim, H. Lee, J. E. Lee, S. Lee, C.-H. Kim, D. W. Kim, E.-K. Jo, et al.
Role of microglial IKK{beta} in kainic acid-induced hippocampal neuronal cell death
Brain,
November 1, 2008;
131(11):
3019 - 3033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thapa and D. J. J. Carr
Herpes Simplex Virus Type 2-Induced Mortality following Genital Infection Is Blocked by Anti-Tumor Necrosis Factor Alpha Antibody in CXCL10-Deficient Mice
J. Virol.,
October 15, 2008;
82(20):
10295 - 10301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hayakawa, K. Mishima, M. Nozako, M. Hazekawa, S. Mishima, M. Fujioka, K. Orito, N. Egashira, K. Iwasaki, and M. Fujiwara
Delayed Treatment With Minocycline Ameliorates Neurologic Impairment Through Activated Microglia Expressing a High-Mobility Group Box1-Inhibiting Mechanism
Stroke,
March 1, 2008;
39(3):
951 - 958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pedrazzi, M. Patrone, M. Passalacqua, E. Ranzato, D. Colamassaro, B. Sparatore, S. Pontremoli, and E. Melloni
Selective Proinflammatory Activation of Astrocytes by High-Mobility Group Box 1 Protein Signaling
J. Immunol.,
December 15, 2007;
179(12):
8525 - 8532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Pichiule, J. C. Chavez, A. M. Schmidt, and S. J. Vannucci
Hypoxia-inducible Factor-1 Mediates Neuronal Expression of the Receptor for Advanced Glycation End Products following Hypoxia/Ischemia
J. Biol. Chem.,
December 14, 2007;
282(50):
36330 - 36340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Liu, S. Mori, H. K. Takahashi, Y. Tomono, H. Wake, T. Kanke, Y. Sato, N. Hiraga, N. Adachi, T. Yoshino, et al.
Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats
FASEB J,
December 1, 2007;
21(14):
3904 - 3916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rouhiainen, S. Tumova, L. Valmu, N. Kalkkinen, and H. Rauvala
Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin)
J. Leukoc. Biol.,
January 1, 2007;
81(1):
49 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|